The Clinical Trials on Alzheimer’s Disease conference (CTAD) is a meeting focused entirely on Alzheimer’s Disease Therapeutic Trials with key leaders in Alzheimer Disease research from Industry and Academia getting together and forming partnerships with the objective of speeding the development of effective treatments to fight the disease.

The 15th annual CTAD conference will be held in San Francisco on November 29 – December 2, 2022. 

Looking forward to seeing you in San Francisco!